David Dreman

Last Update: 11-09-2016

Number of Stocks: 452
Number of New Stocks: 16

Total Value: $165 Mil
Q/Q Turnover: 4%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

David Dreman Watch

  • AbbVie's Imbruvica Has Favorable Response Rate Among Marginal Zone Lymphoma Patients

    On Dec. 5, AbbVie Inc. (NYSE:ABBV) announced through PR Newswire the results regarding whether ibrutinib (Imbruvica), a type of chemotherapy drug for the treatment of patients suffering from relapsed / refractory marginal zone lymphoma (MZL), is effective and safe.

    Marginal zone lymphoma belongs to the family of slow-growing non-Hodgkin's lymphomas. Extranodal MZLs generally occur outside the lymph nodes and involve the mucosa-associated lymphoid tissue of some organs, such as the stomach, the ocular adnexal (eyelid, orbital tissues), gut, salivary glands, bronchial tubes, skin and thyroid. Nodal marginal zone lymphomas involve the lymph nodes direcltly.


  • AbbVie, Johns Hopkins Unite for Cancer Research

    AbbVie Inc. (NYSE:ABBV)  and the Johns Hopkins University School of Medicine will conduct exploration, experimentation and discovery activities related to studying cancer, according to a five-year collaboration agreement.

    The worldwide biopharmaceutical company headquartered in Lake Bluff, Illinois, and Johns Hopkins University School of Medicine, located in Baltimore, announced through PR Newswire yesterday that the agreement encompasses the goal of targeting disparate fields of cancer research, including lung carcinoma, bowel cancer, breast, prostate and blood tumors.


  • HollyFrontier Benefits From Credit Suisse Upgrade

    Credit Suisse upgraded HollyFrontier Corp. (NYSE:HFC), as reported by Barrons, from Neutral to Outperform with a new target price of $38 per share, suggesting to buy this stock even though the firm says it does not exclude the possibility of wide swings in the share price during the month due to “seasonal margins and the recent spike in crude.”

    So far, 2016 has been a disappointing year for HollyFrontier. The stock has lost 22% year to date.


  • Insider Invests in Spectra Energy Partners

    Gregory Ebel (Insider Trades), CEO and president of Spectra Energy Partners (NYSE:SEP), purchased 8,529 shares of the company on Nov. 7. The average price per share was $41.67 for a total transaction of $355,403. Spectra Energy Partners, a master limited partnership in the United States, connects natural gas and crude oil supply to the market. The company has a market cap of $12.73 billion.

    Ebel’s aforementioned transaction is the only insider trade with Spectra in 2016 to date. Director J.D. Woodward (Insider Trades) purchased 3,000 shares in two transactions in December 2015, which have both increased less than 5% in value since then. Directors Theopolis Holeman (Insider Trades) and William Yardley (Insider Trades) acquired 1,000 and 500 shares of the company in 2013. The most recent insider sell of Spectra to date was in March 2010. Director Robert Fiedorek (Insider Trades) sold 5,000 shares of the company for an average per share price of $31. The value has increased by nearly a third since then. For more information about insider trades with Spectra, click here.


  • Seven New Stocks in My Purloined Portfolio

    In the twilight of his career, Kemmons Wilson, the founder of Holiday Inn, ran a smaller chain called Wilson World.

    I visited one of his hotels with Wilson and admired the swim-up bar, a feature I had never seen before. Wilson said that he had seen one at a competitor’s hotel and copied it. He was never ashamed, Wilson said, to take a good idea from a competitor.


  • Dillard's: Has the Pendulum Swung too Far?

    Dillard’s Inc. (NYSE:DDS) - the U.S.-based apparel, cosmetics and home furnishings retailer - has recently taken a beating in the stock market. The stock has declined over 30% in the last 12 months, and economic uncertainty is keeping the price volatile. Although buying at this time may seem like an attempt to catch a falling knife, there are more than a few bright spots where an opportune investor will see a diamond in the rough.



  • Value Investors Avoided Deutsche Bank and 2 Other European Financials

    Value gurus mostly exited Deutsche Bank (NYSE:DB) before its stock tumbled this month on news it might have to pay a large fine related to the financial crisis. While many maintain positions in other European banks as fear weighs on stocks in the sector, they are avoiding two almost as much as Deutsche Bank: Banco Santander SA (NYSE:SAN) and Lloyds Banking Group PLC (NYSE:LYG).

    As early as the second quarter, Deutsche Bank was the least held among portfolios tracked by GuruFocus. The bank represented only 0.03% of collective portfolios, with three holders and 57,139 shares owned among them. Investors who had positions as of second quarter-end were David Dreman (Trades, Portfolio) and John Burbank (Trades, Portfolio), in miniscule amounts. Jim Simons (Trades, Portfolio) of the algorithm-driven Renaissance Technologies, sold 95.8% of his stake.


  • Undervalued Financial Services Companies Among Top Buys

    Among companies trading on the New York Stock Exchange and Nasdaq, financial services companies currently trade below their fair values.

    Two companies, Waddell & Reed Financial Inc. (NYSE:WDR) and Robert Half International Inc. (NYSE:RHI) are undervalued based on multiple valuation methods. As these companies offer good value at bargain prices, several gurus invested in financial services companies during the past six months.


  • Book Review: Contrarian Investment Strategies

    Booms and busts are becoming more frequent in today’s investing environment. In "Contrarian Investment Strategies," David Dreman (Trades, Portfolio) uses modern psychological research to profit from the stock market's inevitable swings.

    David Dreman


  • 12 Questions With Validea Capital Management John Reese

    John Reese is founder and CEO of Validea.com and Validea Capital Management LLC. Validea Capital is the investment adviser to an actively managed equity ETF. Reese has been running quantitative models since 2003. He is a graduate of Harvard Business School and MIT, published author and investment columnist. Reese holds two patents in automated stock analysis.

    1. How and why did you get started investing? What is your background?


  • 10 Stocks David Dreman Is Buying

    David Dreman (Trades, Portfolio) is the founder and chairman of Dreman Value Management, also serving as the firm's chief investment officer. In both the first and second quarters, the firm bought shares in the following stocks.

    Aviva PLC ADR (AV)


  • George Soros Boosts Stake in Synaptics

    George Soros (Trades, Portfolio) increased his stake in Synaptics (NASDAQ:SYNA) elevenfold, adding an additional 180,000 shares in the company to his portfolio during the second quarter. Since the trade Synaptics' market price has tumbled by an estimated 15%.

    Synaptics has a market cap of $2.03 billion, a price-earnings (P/E) ratio of 30.71, an enterprise value of $1.91 billion and a price-book (P/B) ratio of 2.88.


  • Divestitures Dominate Dreman's Top 10 Transactions in 2nd Quarter

    Seven of David Dreman (Trades, Portfolio)’s top 10 transactions in the second quarter were exits from positions that have been in Dreman Value Management’s portfolio for most of the past six years. Dreman is the founder and chairman of the investment company.

    The guru’s most noteworthy divestiture of the quarter was the sale of 809,156 shares in Associated Banc-Corp (NYSE:ASB), a financial services company based in Green Bay, Wisconsin, for an average price of $17.8 per share. The transaction had a -1.66% impact on the portfolio.


  • Insider Sells Shares of American Financial Group

    Craig Lindner (Insider Trades), co-CEO and co-president of American Financial Group Inc. (AFG), sold 75,000 shares for $72.13 per share on Aug. 8. The total transaction was $5,409,750.

    American Financial Group is a holding company based in Cincinnati. The company is engaged mainly in property and casualty insurance with a focus on specialized commericial products for businesses, and the sale of traditional fixed and fixed-indexed annuities. American Financial Group has a market cap of $6.4 billion.


  • Gilead Sciences Insider Sells 112,000 Shares

    John Milligan (Insider Trades), CEO and president of Gilead Sciences Inc. (GILD), sold 112,000 company shares on July 5. The price per share was $84.33 for a total transaction of $9,444,960.

    Gilead Sciences is a global biopharmaceutical company that discovers, develops and commercializes therapies for life-threatening disease. The company has a market cap of $113.83 billion and a P/S ratio of 3.48.


  • Honda Approaches Its 10-Year P/B Ratio Low

    Honda Motor Co. Ltd. (NYSE:HMC) is traded at a P/B ratio of 0.80, close to its 10-year low of 0.72. The company is owned by eight gurus.

    Honda has a market cap of $47.89 billion; its shares were traded around $26.57 with a P/E ratio of 17.38 and P/S ratio of 0.39. The trailing 12-month dividend yield of Honda stock is 2.89%. Honda's forward dividend yield is 3.25%. Honda had an annual average earnings growth of 3.90% over the past 10 years. GuruFocus rated Honda the business predictability rank of 2.5-star.


  • Gap Closes In on Its P/S Ratio 10-year Low

    Gap Inc. (NYSE:GPS) is traded at a P/S ratio of 0.57, close to its 10-year low of 0.46. The company is owned by 10 gurus.

    Gap has a market cap of $8.31 billion; its shares were traded around $20.88 with a P/E ratio of 10.57 and P/S ratio of 0.57. Gap's trailing 12-month dividend yield is 4.42%. The forward dividend yield is 4.46%. Gap had an annual average earnings growth of 10.40% over the past 10 years. GuruFocus rated Gap the business predictability rank of 4-star.


  • Idacorp Is Dreman's Top New Buy of 1st Quarter

    Four of David Dreman (Trades, Portfolio)’s top five new buys in the first quarter were in REITs or financial services companies, but the exception was his biggest acquisition of the quarter.

    Dreman’s largest new buy was the purchase of a 179,153-share stake in Idacorp Inc. (NYSE:IDA), an electricity holding company based in Boise, Idaho. Dreman bought the stake for an average price of $70.5 per share. The transaction had a 1.52% impact on his portfolio.


  • Peter Lynch Targets Undervalued Airline Companies

    In early June, the Peter Lynch screen featured two airline companies, Allegiant Travel Co. (NASDAQ:ALGT) and Southwest Airlines Co. (NYSE:LUV), as two of the most undervalued companies based on their earnings lines. Due to potential upside in the airline industry, many gurus are increasing their positions in airline stocks.

    Peter Lynch and his winning strategy


  • David Dreman Purchases Stake in RAIT Financial Trust

    David Dreman (Trades, Portfolio) purchased a stake in RAIT Financial Trust (NYSE:RAS).



Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)